Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Ermont Inc.
Common stock
Common stock
Ermont Inc.
Common stock subscribed but not issued
Additional paid-in capital
Additional paid-in capital
Ermont Inc.
Accumulated deficit
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2022     341,474,728   70,000        
Beginning balance at Dec. 31, 2022 $ 57,310   $ 341   $ 39 $ 142,365   $ (83,924) $ (1,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock subscribed but not issued (in shares)         5,025        
Common stock subscribed but not issued 2       $ 2        
Issuance of subscribed shares (in shares)     75,025   (75,025)        
Issuance of subscribed shares 0       $ (41) 41      
Release of shares under stock grants (in shares)     599,999            
Release of shares under stock grants 0   $ 1     (1)      
Exercise of stock options (in shares)     487,752            
Exercise of stock options 109         109      
Warrants issued in connection with debt and Standalone warrants issued as payment for services 5,454         5,454      
Conversion of preferred stock to common stock (in shares)     25,304,710            
Conversion of preferred stock to common stock 18,725   $ 25     18,700      
Common stock issued to settle obligations (in shares)     400,000            
Common stock issued to settle obligations 160         160      
Common stock issued under licensing agreement (in shares)     13,007            
Common stock issued under a licensing and royalty agreement 5         5      
Common stock issued to purchase property and equipment (in shares)     740,741            
Common stock issued to purchase property and equipment 300   $ 1     299      
Common stock issued as purchase consideration - business acquisition (in shares)       6,580,390          
Common stock issued as purchase consideration - business acquisition   $ 2,994   $ 7     $ 2,987    
Purchase of minority interest in a subsidiary of the Company (in shares)     450,000            
Purchase of minority interest in a subsidiary of the Company 0   $ 1     4     (5)
Common stock returned to the Company in connection with a cancelled transaction (in shares) [1]     (1,000,000)            
Common stock returned to the Company in connection with a cancelled transaction [1] 0   $ (1)     1      
Distributions to noncontrolling interests (158)               (158)
Stock-based compensation 1,020         1,020      
Net (loss) income (16,007)             (16,031) 24
Ending balance (in shares) at Dec. 31, 2023     375,126,352   0        
Ending balance at Dec. 31, 2023 69,914   $ 375   $ 0 171,144   (99,955) (1,650)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Release of shares under stock grants (in shares)     2,636,750            
Release of shares under stock grants 0   $ 2     (2)      
Shares of newly vested common stock surrendered to the Company to satisfy tax withholding obligations (in shares)     (249,087)            
Shares of newly vested common stock surrendered to the Company to satisfy tax withholding obligations $ (41)         (41)      
Exercise of stock options (in shares) 0                
Warrants issued in connection with debt and Standalone warrants issued as payment for services $ 218         218      
Common stock issued under licensing agreement (in shares)     45,299            
Common stock issued under a licensing and royalty agreement 10         10      
Common stock issued to purchase property and equipment 300                
Common stock issued as purchase consideration - business acquisition (in shares)       3,917,267          
Common stock issued as purchase consideration - business acquisition   $ 991   $ 4     $ 987    
Distributions to noncontrolling interests (139)               (139)
Stock-based compensation 1,050         1,050      
Net (loss) income (12,127)             (12,164) 37
Ending balance (in shares) at Dec. 31, 2024     381,476,581   0        
Ending balance at Dec. 31, 2024 $ 59,876   $ 381   $ 0 $ 173,366   $ (112,119) $ (1,752)
[1] Represents shares initially issued in connection with an acquisitive transaction that was subsequently cancelled, at which time the shares were returned to the Company and recorded at par value.